Form 4 for TLSI TriSalus Life Sciences, Inc.
Accepted 2025-01-06 00:00:00 ET · period of report 2025-01-02 · accession 0001415889-25-000828 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-06 | 2025-01-02 | TLSI | Hyveled Liselotte | Dir | A - Grant | $0.00 | +10.0K | 10.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-02 | A | A | 10,040 | $0.00 | 10,040 | D | — | — | (F1) Represents grant of Restricted Stock Units (the "RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the RSU Award in lieu of the 2025 cash Annual Board Service Retainer provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the RSU Award shall vest in equal quarterly installments on each of March 31, June 30, September 30 and December 31, 2025, subject to the Reporting Person's continued service with the Issuer. |